7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Novartis
(NYSE:NVS) 

NVS stock logo

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology,...

Founded: 1996
Full Time Employees: 110,000
Sector: Healthcare
Industry: Drug Manufacturers-General
blind

Share this website to your friends
Novartis Number of Twitter Followers
202204 202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 043.3486.68130.02173.36216.7260.04303.38Thousand
Novartis Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 018.1836.3654.5572.7390.91109.09127.27
Novartis Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 09.5819.1728.7538.3447.9257.567.09
Novartis Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 026.5653.1379.69106.26132.82159.38185.95
Novartis Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.112.223.334.445.556.667.77
Novartis Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.921.832.753.674.585.56.41
Novartis Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.282.573.855.146.427.78.99
Novartis P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.61.211.812.423.023.634.23
Novartis (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 04.498.9913.4817.9722.4626.9631.45
Novartis P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.821.642.463.284.14.925.74
No extra charts and metrics for this ticker.